The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes (AddHope2)

This study is currently recruiting participants.
Verified May 2012 by Haugaard, Steen Bendix, M.D., DMSc
Sponsor:
Information provided by (Responsible Party):
Haugaard, Steen Bendix, M.D., DMSc
ClinicalTrials.gov Identifier:
NCT01595789
First received: May 8, 2012
Last updated: October 11, 2013
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2015
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)